Delivery Order SPE2DB24D2205-SPE2DB25FEFJR
Award Date 7/24/25
Potential Completion Date 7/25/25
Potential Value $43K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of 100 mg Dasatinib tablets, with a ceiling value of $27,673.65 and a period of performance through June 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a for-profit corporate entity that serves as a critical supplier of medical and pharmaceutical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DASATINIB 80 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price of $12,790.96 and a period of performance ending on July 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 30-count bottles of the prescription medication Dasatinib 80 mg tablets, with a total ceiling value of $8,260.58 and a final completion date of July 10, 2025. The contract is not set aside and was awarded on July 9, 2025. Amerisourcebergen Drug Corp is a for-profit...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DASATINIB 50 MG TABLET 60S, a prescription medication, with a firm fixed price ceiling value of $21,359.55 and a performance period ending on June 16, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a $6,653.47 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DASATINIB 70 MG TABLET 60S, a prescription medication. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, which provides a...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the delivery of Sprycel (Dasatinib) 100 mg tablets. The contract, valued at $45,165.44, has a completion date of November 22, 2022 and is a Firm Fixed Price arrangement. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,013.24 on July 25, 2025, for the supply of Sprycel 100 mg tablets (30-count packages). This competitively awarded, firm fixed-price contract is non-set-aside and specifies a completion date of July 28, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Imatinib Mesylate 400 mg tablets in quantities of 30 units at a firm fixed price of $1,252.05. This order, which represents a non-competitive set-aside contract, is due for completion by July 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this delivery through its...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a $16,304.05 delivery order for the drug Sprycel (Dasatinib) 140mg tablets. The award has no set-aside designation and is a firm-fixed-price contract type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,341.10 fixed-price delivery order is for 60 tablets of the medication Sprycel (dasatinib) 50 mg. This award does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...